- Home
- REPL vs BZH Comparison
REPL vs BZH Comparison
Compare REPL & BZH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REPL
- BZH
- Stock Information
- Founded
- REPL 2015
- BZH 1985
- Country
- REPL United States
- BZH United States
- Employees
- REPL N/A
- BZH N/A
- Industry
- REPL Biotechnology: Pharmaceutical Preparations
- BZH Homebuilding
- Sector
- REPL Health Care
- BZH Consumer Discretionary
- Exchange
- REPL Nasdaq
- BZH Nasdaq
- Market Cap
- REPL 757.8M
- BZH 666.1M
- IPO Year
- REPL 2018
- BZH 1994
- Fundamental
- Price
- REPL $9.35
- BZH $23.09
- Analyst Decision
- REPL Strong Buy
- BZH Strong Buy
- Analyst Count
- REPL 7
- BZH 3
- Target Price
- REPL $20.83
- BZH $33.00
- AVG Volume (30 Days)
- REPL 1.1M
- BZH 332.4K
- Earning Date
- REPL 08-07-2025
- BZH 07-31-2025
- Dividend Yield
- REPL N/A
- BZH N/A
- EPS Growth
- REPL N/A
- BZH N/A
- EPS
- REPL N/A
- BZH 3.10
- Revenue
- REPL N/A
- BZH $2,436,131,000.00
- Revenue This Year
- REPL N/A
- BZH N/A
- Revenue Next Year
- REPL N/A
- BZH $14.27
- P/E Ratio
- REPL N/A
- BZH $7.22
- Revenue Growth
- REPL N/A
- BZH 13.50
- 52 Week Low
- REPL $6.44
- BZH $17.37
- 52 Week High
- REPL $17.00
- BZH $38.22
- Technical
- Relative Strength Index (RSI)
- REPL 49.55
- BZH 57.43
- Support Level
- REPL $8.92
- BZH $21.73
- Resistance Level
- REPL $9.93
- BZH $22.84
- Average True Range (ATR)
- REPL 0.52
- BZH 0.75
- MACD
- REPL -0.08
- BZH 0.02
- Stochastic Oscillator
- REPL 22.40
- BZH 61.61
About REPL Replimune Group Inc.
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3. The company operates in USA and UK, majority of revenue from USA.
About BZH Beazer Homes USA Inc.
Beazer Homes USA Inc is an construction company that focuses on residential construction. The company specializes in single-family housing and multi-unit building construction in over 13 states and over 22 metro markets. Beazer Homes builds homes and communities that target first-time, move-up, and luxury homebuyers with an average selling price of roughly $300,000. From a geographic perspective, home sales in the western and eastern United States have been the leading sources of revenue for the company. Key metro areas include Atlanta, Las Vegas, Los Angeles, Orlando, and Tampa. The company also focuses on land purchasing and development to support future construction efforts as well as mortgage services for its homebuyers.